§ 63-1-403. Nonresidential Buprenorphine Treatment Guidelines
As used in this section: “Commissioners” means the commissioner of mental health and substance abuse services and the commissioner of health; and “Nonresidential buprenorphine treatment guidelines” means systematically developed standards to assist any practitioners authorized by the state to prescribe buprenorphine-containing products for the treatment of opioid use disorder as defined in the latest version […]
§ 63-1-501. Short Title
This part shall be known and may be cited as the “Health Care Empowerment Act.”
§ 63-1-502. Part Definitions
As used in this part: “Direct medical care agreement” means a written contractual agreement between a direct medical care provider and an individual patient, or the patient’s legal representative, in which: The direct medical care provider agrees to provide medical care services to the individual patient for an agreed fee over an agreed period of […]
§ 63-1-503. Purchase and Payment of Medical Services or Products Outside of Insurance Plan or Outside of Tenncare or Medicare Program Not Prohibited
Nothing in state law prohibits a patient or a legal representative of a patient from seeking care outside of an insurance plan, or outside of the TennCare or Medicare program, and paying for that care. Nothing in state law prohibits a medical care provider licensed under this title, or a healthcare facility, licensed under title […]
§ 63-1-504. Direct Medical Care Agreement
A direct medical care agreement is not insurance and is not subject to regulation by the department of commerce and insurance. Entering into a direct medical care agreement is not the business of insurance and is not subject to regulation under title 56. A direct medical care provider, or the agent of a direct medical […]
§ 63-1-601. Reporting Suspected Opiod Abuse or Diversion
The department of health shall accept allegations of opioid abuse or diversion. The department shall publicize a means of reporting allegations of opioid abuse or diversion. Any entity that prescribes, dispenses, or handles opioids shall provide information to employees about reporting suspected opioid abuse or diversion. The information may be provided to each employee individually […]
§ 63-1-602. Protection of Employees or Persons Who Report Information Relative to Opiod Abuse or Diversion
No employee of an entity that prescribes, dispenses, or handles opioids shall be discharged or terminated solely for reporting information in good faith to the department of health. No person licensed under this title shall suffer an adverse licensure action solely for reporting information in good faith to the department of health. A person who […]
§ 63-1-319. Annual Report by Medical Director of Pain Management Clinic
The medical director of each pain management clinic shall report annually to the department of health, on a form promulgated by the department, the following: The number of physicians, physician assistants, and advanced practice registered nurses who are working in the clinic for each month; The number of patients seen by the clinic for each […]
§ 63-1-320. Providing Rules to Health Committee and Health and Welfare Committee
Notwithstanding this part or the Uniform Administrative Procedures Act, compiled in title 4, chapter 5, any rule promulgated to implement this part shall be provided to the chairs of the health committee of the house of representatives and the health and welfare committee of the senate by the secretary of state, after approval by the […]
§ 63-1-401. Part Definitions — Development of Recommended Treatment Guidelines for Prescribing Opioids — Development of Pain Clinic Guidelines — Study of Co-Prescription of Naloxone With Opioid — Review of Guidelines — Notification of Licensees
As used in this part: “Commissioner” means the commissioner of health; “Pain clinic guidelines” means systematically developed standards to assist healthcare providers and pain clinic certificate holders in making decisions concerning the appropriate medical care for chronic nonmalignant pain treatment, as defined in § 63-1-301; and “Treatment guidelines” means systematically developed statements to assist healthcare […]